
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $59.5M | -- | -- | $0.30 | -- |
08/07/2025 | Q2 | $56.6M | -- | -- | $0.23 | -- |
06/09/2025 | Q1 | $55.7M | $59.3M | $0.40 | $0.19 | $0.21 |
02/07/2025 | Q4 | $49.5M | $47M | $0.14 | $0.08 | $0.07 |
11/08/2024 | Q3 | $49.7M | $53.6M | $0.30 | $0.13 | $0.17 |
08/07/2024 | Q2 | $50.1M | $50M | $0.27 | $0.18 | $0.09 |
06/07/2024 | Q1 | $44.5M | $49.1M | $0.12 | -- | -- |
02/05/2024 | Q4 | $38.9M | $43.8M | $0.02 | -- | -- |
11/06/2023 | Q3 | $41.9M | $45.1M | $0.04 | -- | -- |
08/07/2023 | Q2 | $40M | $47.6M | $0.25 | -- | -- |
06/08/2023 | Q1 | $36.5M | $43M | -$0.05 | -- | -- |
02/06/2023 | Q4 | -- | $39.9M | $0.03 | -- | -- |
11/07/2022 | Q3 | -- | $38.1M | -$0.02 | -- | -- |
07/29/2022 | Q2 | -- | $36.1M | $0.06 | -- | -- |
06/08/2022 | Q1 | -- | $39.7M | -$0.13 | -- | -- |
02/07/2022 | Q4 | -- | $28.8M | -$0.35 | -- | -- |
10/27/2021 | Q3 | -- | $34.1M | -$0.05 | -- | -- |
08/10/2021 | Q2 | -- | $20.2M | -$0.31 | -- | -- |
06/01/2021 | Q1 | -- | $25.7M | $0.04 | -- | -- |
01/28/2021 | Q4 | -- | $27.2M | $0.11 | -- | -- |
10/28/2020 | Q3 | -- | $28M | $0.27 | -- | -- |
07/30/2020 | Q2 | -- | $16.7M | -$0.18 | -- | -- |
06/10/2020 | Q1 | -- | $23.1M | $0.06 | -- | -- |
01/29/2020 | Q4 | -- | $25.3M | $0.00 | -- | -- |
10/30/2019 | Q3 | -- | $21.6M | $0.12 | -- | -- |
07/26/2019 | Q2 | -- | $20.6M | $0.01 | -- | -- |
05/30/2019 | Q1 | -- | $23.6M | -$0.46 | -- | -- |
01/30/2019 | Q4 | -- | $17.2M | $0.01 | -- | -- |
11/08/2018 | Q3 | -- | $21.4M | $0.19 | -- | -- |
08/03/2018 | Q2 | -- | $29.6M | $0.24 | -- | -- |
05/31/2018 | Q1 | -- | $22.2M | $0.09 | -- | -- |
02/01/2018 | Q4 | -- | $17.3M | -$1.19 | -- | -- |
10/25/2017 | Q3 | -- | $17.2M | $0.00 | -- | -- |
08/04/2017 | Q2 | -- | $20.9M | $0.10 | -- | -- |
06/01/2017 | Q1 | -- | $25.6M | $0.18 | -- | -- |
02/01/2017 | Q4 | -- | $22.7M | $0.19 | -- | -- |
11/01/2016 | Q3 | -- | $21.1M | $0.13 | -- | -- |
07/29/2016 | Q2 | -- | $22.4M | $0.01 | -- | -- |
05/25/2016 | Q1 | -- | $22.3M | $0.05 | -- | -- |
01/29/2016 | Q4 | -- | $17.3M | $0.13 | -- | -- |
10/28/2015 | Q3 | -- | $22.8M | $0.20 | -- | -- |
Graham reported $59.3M worth of top line sales in its most recent quarter.
Graham announced earnings per share of $0.40 which represents a beat of analyst forecast a $0.19 per share.
Graham reported $16M that represents $1.43 per share over the last quarter.
Graham's earnings are forecast to decrease from $1.11 per share to $1.00 per share next year representing a decrease of -1.35%.
Graham's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.